Clinical

Precision BioSciences Outlines Clinical Development Strategy for In Vivo Gene Editing Pipeline

22 minutes ago   |   Precision Biosciences   |   6 articles

Accelerated Clinical Development Expected to Enable Three Investigational New Drug/Clinical Trial Applications Within Next Three Years, Including for Familial...
Read more ...

Precision BioSciences to Present at H.C. Wainwright 23rd Annual Global Investment Conference

22 minutes ago   |   Precision Biosciences   |   6 articles

DURHAM, N.C. --Sep. 10, 2021- Precision BioSciences, Inc. , a clinical stage biotechnology company developing allogeneic CAR T and in vivo gene correction therapies with its...
Read more ...

Preliminary Safety and Efficacy of PBCAR0191, an Allogeneic, Off-the-Shelf CD19-Targeting CAR-T Product, in Relapsed/Refractory CD19+ NHL

22 minutes ago   |   Precision Biosciences   |   6 articles

Shah, B.D. et al. American Society of Clinical Oncology 2021 Annual Meeting.
Read more ...

Precision BioSciences Appoints Michael Amoroso Chief Executive Officer

22 minutes ago   |   Precision Biosciences   |   6 articles

DURHAM, N.C. --Sep. 27, 2021- Precision BioSciences, Inc. , a clinical stage biotechnology company using its ARCUS genome editing platform to develop allogeneic CAR T and in...
Read more ...

Precision BioSciences Announces Grant of Inducement Award for Newly Appointed Chief Executive Officer Pursuant to Nasdaq Listing Rule 5635(4)

22 minutes ago   |   Precision Biosciences   |   6 articles

DURHAM, N.C. --Sep. 27, 2021- Precision BioSciences, Inc. , a clinical stage biotechnology company using its ARCUS® genome editing platform to develop allogeneic CAR T and in...
Read more ...

Precision BioSciences Statement on Safety of its Allogeneic CAR T Cells

22 minutes ago   |   Precision Biosciences   |   6 articles

Precision BioSciences, Inc. , a clinical stage biotechnology company using its ARCUS® genome editing platform to develop allogeneic CAR T and in vivo gene editing therapies...
Read more ...

Pharma veterans regroup with $50M and a plan to discover new multi-specifics

8 hours ago   |   San Diego Biotechnology

While a horde of drugmakers develops bispecific antibodies to more directly target tumor cells - there were about 100 programs in or nearing clinical trials back in May - a new...
Read more ...

Natalie Rodriguez: The Whole Person

Natalie Rodriguez: The Whole Person

23 hours ago   |   San Diego Biotechnology

As San Diegans settle down to watch the sunset at Pacific Beach, the Student-Run Free Clinic Project picks up speed a few blocks away. Health care workers move through the...
Read more ...

Oncolytics Biotech®Partner Adlai Nortye Doses First Patient in Chinese Bridging Trial Evaluating Pelareorep-Paclitaxel Combination Treatment in Breast Cancer

1 day ago   |   San Diego Biotechnology   |   3 articles

SAN DIEGO and CALGARY, AB: Trial is designed to advance pelareorep's clinical development in China, the world's second-largest pharmaceutical market SAN DIEGO and CALGARY, AB...
Read more ...

Manager, Clinical Biomarker Assay Lead - Pfizer - La Jolla, CA

1 day ago   |   San Diego Biotechnology   |   2 articles

Key point of contact with internal labs, external vendors, and academic clinical laboratories, with oversight responsibilities for agreements, work plans,...From Pfizer - Thu...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Long-Term Stable Reduction of Low-Density Lipoprotein in Nonhuman Primates...

Wang, L. et al. Molecular Therapy. 6, 2019-2029 (2021). Read more ...

Mitochondrial Targeted Meganuclease as a Platform to Eliminate Mutant mtDNA...

Zekonyte, U. et al. Nat Commun. 12, 3210 (2021). Read more ...

Scientists map brain circuit that drives activity in fertile females

Scientists have known for a century that female animals become more active just as they are about to ovulate, a behavior that evolved to enhance their chances of mating when... Read more ...

A new method inspired by kid's pop-up books for making 3D artificial tissue

University at Buffalo researchers have developed a new process for creating three-dimensional artificial tissue, an advancement that could improve experimental drug testing... Read more ...

Inhalable anti-COVID-19 antibody from TFF and Augmenta tamps down viral load...

Inhalable anti-COVID-19 antibody from TFF and Augmenta tamps down viral load in hamsters arlene.weintraub Fri, 10/15/2021 - 08:26 Read more ...

AstraZeneca delivers rare win for treme in liver cancer, bouncing back from...

AstraZeneca delivers rare win for treme in liver cancer, bouncing back from flops to beat Bayer's Nexavar ntaylor Fri, 10/15/2021 - 07:58 Read more ...

Pharma veterans regroup with $50M and a plan to discover new multi-specifics

While a horde of drugmakers develops bispecific antibodies to more directly target tumor cells - there were about 100 programs in or nearing clinical trials back in May - a new... Read more ...

Chinese biopharma powerhouse continues charge into siRNA with Silence R&D pact

Chinese biopharma powerhouse continues charge into siRNA with Silence R&D pact ntaylor Fri, 10/15/2021 - 04:33 Read more ...

Quantitative prediction model for affinity of drug-target interactions based...

The study of drug-target interactions affinity plays an important role in safety assessment and pharmacology. Currently, quantitative structure-activity relationship and... Read more ...

Modularity‐based Parallel Protein Design Algorithm with an Implementation...

Abstract Given a target protein structure, the prime objective of protein design is to find amino acid sequences that will fold/acquire to the given three-dimensional... Read more ...